Collegium Pharmaceutical, Inc (COLL)

Last Three Months

02-Nov-22 -- 01-Feb-23

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drugs - Generic

Drugs

Insider Trading Sentiment: Reduce

Insider Trading Sentiment: Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

22

0

0

+1

0

+2

0

+3

Two Year Chart

02-Feb-21 -- 01-Feb-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Dec-22 7:16 PM View:	27-Dec-22 Sale (Planned) ($52.34K)	Ciaffoni Joseph President and CEO Director		Collegium Pharmaceutical, Inc - COLL	(23%) 323.45K to 248.75K	0	0	--	--	Show Txns Hide Txns

11-Jan-23 4:06 PM View:	09-Jan-23 Private Sale (Planned) ($488.55K)	Dreyer Scott EVP & Chief Commercial Officer		Collegium Pharmaceutical, Inc - COLL	(15%) 120.63K to 102.8K	0	0	--	--	Show Txns Hide Txns

27-Dec-22 7:17 PM View:	27-Dec-22 Planned Option Sale ($470.25K)	Heffernan Michael Thomas Director		Collegium Pharmaceutical, Inc - COLL	0% 28.02K	0	0	--	--	Show Txns Hide Txns